Olivia Creser

Associate
Full contact info

Experience

Abivax Announces $235.8 Million IPO

October 20, 2023

Cooley advised Abivax, a clinical-stage biotech company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases, on its $235.8 million initial public offering.

Read more

Related contacts

Div Gupta
Partner, New York
Marc Recht
Partner, Boston
Ryan Sansom
Partner, Boston
Denny Won
Partner, San Francisco
Aaron Pomeroy
Partner, Colorado
Richard Segal
Partner, New York
Nyron J. Persaud
Partner, New York
Madhuri Roy
Partner, Palo Alto
Courtney Thorne
Partner, Boston
Elizabeth Anne Wright
Of Counsel, Brussels
Xander Lee
Partner, Los Angeles Santa Monica
Phil Mitchell
Partner, New York
Stephanie Gentile
Partner, New York
Kevin King
Partner, Washington, DC
Katie Kazem
Partner, Reston
Natasha Leskovsek
Of Counsel, Washington, DC
Rebecca Ross
Special Counsel, Washington, DC
Randy Sabett
Special Counsel, Washington, DC
Jennifer Shanley
Special Counsel, New York
Reid Hooper
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Minkyu Park
Associate, New York
Jesse Schulman
Associate, Washington, DC
Barry Kuang
Associate, Boston
Olivia Creser
Associate, New York
Peter A. Haddad
Associate, San Diego
Samuel Paullin
Associate, Chicago
Evan Leitner
Associate, New York
Rick Jantz
Associate, Los Angeles Santa Monica
Cara Buchicchio
Associate, New York
Jason Valentine
Associate, Washington, DC
Jessica Koffel
Associate, Brussels
Mor Agam
Associate, New York
Cathy Rude
Paralegal Specialist, Boston

Related Practices & Industries

Zoetis – $1.35 Billion Investment Grade Bond Offering

November 8, 2022

Cooley advised Zoetis on its $1.35 billion aggregate principal amount of investment-grade unsecured senior notes, $600 million of 5.400% senior notes due 2025, and $750 million of 5.600% senior notes due 2032. Zoetis is a global leader in the animal health industry, focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. Eric Blanchard and Madison Jones led the Cooley team.

Related contacts

Eric Blanchard
Partner, Boston
Madison Jones
Partner, Washington, DC
Katherine Denby
Associate, Washington, DC
Olivia Creser
Associate, New York

Related Practices & Industries

Verona Pharma – $150 Million Follow-on Offering

September 2, 2022

Cooley advised the underwriters in Verona Pharma’s $150 million follow-on offering of 14,260,000 American depositary shares at a public offering price of $10.50 per American depositary share. Verona is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapeutics for the treatment of respiratory diseases with significant unmet medical needs. Lawyers Daniel Goldberg, Eric Blanchard, Div Gupta, Charlie Kim, Minkyu Park, Amiti Rothstein and Olivia Creser led the Cooley team.

Related contacts

Daniel I. Goldberg
Partner, New York
Div Gupta
Partner, New York
Eric Blanchard
Partner, Boston
Charlie Kim
Partner, San Diego
Minkyu Park
Associate, New York
Amiti C. Rothstein
Associate, New York
Olivia Creser
Associate, New York

Related Practices & Industries

Zentalis Pharmaceuticals – $200 Million Follow-On Offering

July 8, 2022

Cooley advised the underwriters in Zentalis Pharmaceuticals’ $200 million follow-on offering of 10,330,000 shares of common stock at an offering price of $19.38 per share. Zentalis is a clinical-stage biopharmaceutical company developing small-molecule therapeutics targeting fundamental biological pathways of cancers. Partners Richard Segal and Div Gupta led the Cooley team.

Related contacts

Richard Segal
Partner, New York
Div Gupta
Partner, New York
Evan Leitner
Associate, New York
Olivia Creser
Associate, New York

Related Practices & Industries

Arbor Realty Trust – $123 Million Offering

July 8, 2022

Cooley advised the underwriters on Arbor Realty Trust’s $123.9 million offering of 7,475,000 shares at $16.57 per share. Arbor Realty Trust is a national direct lender that provides debt capital for the multifamily loan and commercial real estate industries. Partners Daniel Goldberg, Josh Kaufman and Courtney M.W. Tygesson led the Cooley team.

Related contacts

Daniel I. Goldberg
Partner, New York
Courtney M.W. Tygesson
Partner, Chicago
Amiti C. Rothstein
Associate, New York
Olivia Creser
Associate, New York

Related Practices & Industries

Admissions & credentials

New York